Target intelligence / Profile preview

Protein phosphatase 1 regulatory inhibitor subunit 2 pseudogene 1 (PPP1R2P1)

Target
PPP1R2P1
Molecular classification
Other (Pseudogene)
01

Overview

Protein phosphatase 1 regulatory inhibitor subunit 2 pseudogene 1 (PPP1R2P1) is classified as a pseudogene and is predicted to be involved in protein phosphatase inhibitor activity and possibly intracellular signal transduction[1]. However, as a pseudogene, it is generally not believed to encode a functional protein and is not recognized as a therapeutic target. There is no evidence to support a direct role in disease, drug interaction, or biomarker use[1].\nPPP1R2P1 is annotated by major databases as a non-coding pseudogene, not a functional receptor, enzyme, transporter, or other canonical drug target[1]. While the gene product is predicted (based on similarity) to potentially have protein phosphatase inhibitor activity, current evidence does not support a functional, druggable protein product. Pseudogenes such as PPP1R2P1 generally do not encode proteins and are not typically considered in therapeutic targeting, biomarker strategies, or pharmacological safety monitoring. If a functional role outside of classical pseudogene annotation were discovered in the future, this information could change. The current consensus, however, is that it is not a therapeutic target and the target name is not incorrect per se, but the gene itself is not functionally relevant for drug development or disease association[1].

Other names
Putative protein phosphatase inhibitor 2-like protein 1PPP1R2P1IPP-2PPPP1R2PProtein phosphatase 1, regulatory subunit 2 pseudogene 1

Beyond the preview

Go deeper on Protein phosphatase 1 regulatory inhibitor subunit 2 pseudogene 1 (PPP1R2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1 regulatory inhibitor subunit 2 pseudogene 1 (PPP1R2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call